Dr. Anjlee Agarwal, is a National Award recipient and a pioneer in universal accessibility and sustainable mobility. In conversation with The Navhind Times, ...
Andy, who has retinal dystrophy, initially had avoidance anxiety and "wouldn't cross a road, wouldn't take the kids to school ...
11don MSN
Impact of potential hour reduction for Nebraskans needing 24/7 care, Papillion family speaks up
“They're not looking at the bigger picture; they're just looking at dollar signs. I don't want to be labeled as a dollar sign ...
11d
Families urge lawmakers, DHHS to stop Medicaid waiver caps for Nebraskans with disabilities, elderly
Derek Caster, a 30-year-old Nebraskan with Duchenne muscular dystrophy, worries that proposed changes to how the State of ...
Muscular Dystrophy Association Marks Rare Disease Day by Spotlighting Community Stories Driving Progress in Research, Care, and Advocacy ...
The Muscular Dystrophy Association (MDA) is proud to announce the recipients of the 2026 MDA Legacy Awards, recognizing excellence in scientific and clinical research and saluting outstanding ...
Boca Raton, FL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO ...
Sarepta Therapeutics (NASDAQ:SRPT) reported three-year top-line results from its EMBARK Phase 3 pivotal trial evaluating ...
Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...
Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...
Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases. Read why I am bullish about DYN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results